Schedule 13G ownership disclosure

MABVAX THERAPEUTICS HLDGS INC COM

Security class unavailable · CUSIP: 55414P108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,305,488
Percent of class
6.1370%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-15-002914
Form type
SC 13G
Filer
ALPHA CAPITAL ANSTALT
CIK
CIK 1140358
Filed
Apr 22, 2015
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub